Discover the best details about centres and clinics of canada provides comprehensive care for individuals with breast health problems or breast cancer.
Breast cancer is the most common cancer among canadian women with an estimated 24,400 diagnoses every year. Breast imaging, diagnostics, treatment programs, counselling services, research and a clinical trials unit are the best services in the country. Health-care institutions across the country are looking at the integrative model as they try to find ways to improve patient outcomes and maximize efficiency at a time when hospital beds and funding are at a critical shortage.Breast cancer is a disease in which cancer cells grow in the breast tissue. A normal breast consists of glandular tissue called lobes; these lobes are sectioned off into lobules, which produce milk that is carried to the nipple by small ducts. All this tissue is surrounded by fatty and connective tissue, as well as blood and lymph vessels. A new 28,000-square-foot, state-of-the-art breast-cancer centre at Sunnybrook Health Sciences Centre in Toronto will change all that, offering patients everything from next-day diagnosis to participation in innovative clinical trials to immediate post-operative breast reconstruction.
Treatments and procedures at canadian centres
Canadian women get better, shorter treatment for breast cancer than American women according to a new study beacause there are many options to teat successfully. Breast-conserving surgery is an operation that removes the tumour and some of the healthy tissue around it. This type of surgery allows a woman to keep, or conserve, as much of her breast as possible. Often the breast is a little different after BCS, but the changes are often not very noticeable. After surgery, the breast is smaller, slightly different in shape and slightly firmer. In most cases, BCS will be followed by radiation therapy. Breast cancer surgery is the most common treatment for early stage breast cancer. Surgical options include breast removal (mastectomy) or breast conserving surgery (lumpectomy with radiation therapy). Long-term survival is similar with both surgical treatments. Researchers analyzed data from more than 57,800 women across Canada who had breast cancer surgery between 2007 to 2008 and 2009 to 2010. Patients younger than 49 and older than 70 had a higher mastectomy rate (48 percent) than middle-aged patients (40 percent).
Top Breast cancer centres and clinics in canada
Sunnybrook – Temerty Breast Cancer Centre
Sunnybrook is marking the opening of its new Louise Temerty Breast Cancer Centre, which provides tailored care to thousands of patients. The Centre is the largest in the country and features expanded areas for specialized clinics, integrated breast imaging research and clinical trials. “At Sunnybrook, we continue to make strides in vision to invent the future of patient care,” said Dr. Barry McLellan, Sunnybrook’s President and CEO. “This new facility, as a key part of Odette Cancer Program, represents a national centre of excellence that makes the most of the expertise and leading practices of teams. It provides women with the best in breast cancer care. The centre deeply appreciates the generosity of funding partners and donors who helped bring this Centre to life.”
The Centre also provides direct access to breast imaging and diagnostic services for patients and for women participating in the Ontario Breast Screening and Ontario High Risk Screening programs. “Women with breast cancer are not all the same. It affects women from their 20s to later in life. Each woman has different needs across the spectrum of breast care,” said Dr. Eileen Rakovitch, Director of the Louise Temerty Breast Cancer Centre and Head of the Odette Cancer Program’s Breast Cancer Care Team.
Princess Margaret Cancer Centre, Ontario
Princess Margaret Cancer Centre is the largest cancer research and clinical program in Canada. The centre and staff members treat over 19,000 new patients a year and over 1,000 patients visit the hospital daily. Princess Margaret Cancer Centre’s ability to discover and deliver new and better treatments through evidenced-based research. They care for many of Canada’s most complex and challenging cancer patients. The staff members have the expertise to treat the 200+ types of cancer, including the rarest forms of the disease such as eye cancer. They provide consultations to other cancer clinicians across the country and beyond. Because they support the full spectrum of cancer research, uniquely equipped with the world-class expertise to effectively test combinations of treatment therapies. The centre is leading the way with the most comprehensive Immune Therapy Program in Canada. In 2013, they opened Canada’s first clinical trial using a promising kind of Immune Therapy called “Adoptive T-cell Therapy”. They are the only centre in Canada at this time which is integrating the results of genome sequencing of tumour tissue into the patient record for physicians to consider in diagnosis and treatment recommendations through impact and compact clinical trials. The centre has launched several award-winning patient education and survivorship programs, including: Healing Beyond the Body, Survivorship Kitchens, Community Connections, exercise programs and symptom management.
Willow Breast & Hereditary Cancer Support
Willow provides free-of-cost support, insight and information to anyone affected by breast cancer or hereditary cancer, including those at high risk. Willow endeavours to ensure that no one, from the individual diagnosed to their family and caregivers, needs to face it alone. Everyone at Willow has been personally affected by cancer, so the members understand the importance of connecting with someone who “gets it”. The staff and volunteers at Willow bring a human lens to cancer and its treatment. The staff members strive to create a safe place so people can be themselves, ask the tough questions and get support, information, insights and resources, from people who’ve been there themselves.
Mount Sinai Hospital
Mount Sinai Hospital has many areas designed to deliver care to patients, research for the health care and scientific communities, and teaching for the future of health care in Canada.
Familial Breast Cancer Research Unit
The Familial Breast Cancer Research Unit, led by Tier 1 Canada Research Chair Dr. Steven Narod, is a world leader in the study of inherited cancers. With a particular focus on breast and ovarian cancers, Dr. Narod leads this WCRI team in the study of genetic mutations that are known to increase the risk of many cancers – most notably the BRCA1 and BRCA2 mutations. Through its extensive research, publications, data collection, genetic testing programs and collaborations, the team has become an internationally renowned leader in identifying and developing effective strategies to prevent and manage these cancers women and families with a high inherited risk.
CIBC Breast Centre
The CIBC Breast Centre is a premier facility offering a complete range of assessment, diagnostic and treatment services for women of all ages. Full breast screening services, including clinical breast examinations and mammographies are offered by certified nurses and mammography specialists. The members are not only dedicated to treatment and research, but they are also focused on advancing breast cancer care and prevention. They ensure that each patient is cared for in a comprehensive manner, addressing physical and psychosocial needs.
This year was another great year for the Canadian Breast Cancer Foundation CIBC Run for the Cure and none of it would have been possible without you. 127,000 participants and volunteers came together on Run day and through the support of generous donors raised over $25 million for innovative breast cancer research, health education, and advocacy initiatives throughout Canada. You make this inspiring and emotional day possible and it is my pleasure to say ‘thank you’ for making it such a success.
Campbell Family Institute for Breast Cancer Research
Dr. Berman is a clinical breast pathologist and has both clinical and research interests in breast cancer. Dr. Berman’s research focuses on identifying early events in breast carcinogenesis toward the goal of risk assessment and prevention of the disease. Dr. Boyd’s research focuses on developing breast cancer prevention strategies. He has pioneered research in the new area of breast density and was the first to identify it as a major risk factor for breast cancer that can be inherited. Dr. Done is a breast pathologist and an Associate Professor at the University of Toronto.